{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:14:41Z","timestamp":1790673281591,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","techvir.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Techniques in Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1053\/j.tvir.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,11,16]],"date-time":"2014-11-16T20:26:51Z","timestamp":1416169611000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Raynaud Syndrome"],"prefix":"10.1053","volume":"17","author":[{"given":"Sergio Toledo","family":"Valdovinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.tvir.2014.11.004_bib1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0733-8651(02)00068-1","article-title":"Upper extremity arterial disease","volume":"20","author":"Greenfield","year":"2002","journal-title":"Cardiol Clin"},{"key":"10.1053\/j.tvir.2014.11.004_bib2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00000658-197202000-00024","article-title":"An abnormal finger pulse associated with cold sensitivity","volume":"175","author":"Sumner","year":"1972","journal-title":"Ann Surg"},{"key":"10.1053\/j.tvir.2014.11.004_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.autrev.2013.12.001","article-title":"Raynaud\u05f3s phenomenon: From molecular pathogenesis to therapy","volume":"13","author":"Prete","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.tvir.2014.11.004_bib4","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jvs.2013.03.012","article-title":"Current medical and surgical management of Raynaud\u2019s s\u00edndrome","volume":"57","author":"Landry","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.tvir.2014.11.004_bib5","first-page":"858","article-title":"Inefficacy of diltiazem in the treatment of Raynaud\u2019s phenomenon with associated connective tissue disease: a double blind placebo controlled study","volume":"14","author":"Da Costa","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1053\/j.tvir.2014.11.004_bib6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archinte.160.8.1101","article-title":"Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon: Results from a randomized clinical trial with 1-year follow-up","volume":"160","author":"Raynaud\u2019s Treatment Study Investigators","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.tvir.2014.11.004_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/keh390","article-title":"Calcium channel blockers for primary Raynaud\u05f3s phenomenon: A meta-analysis","volume":"44","author":"Thompson","year":"2005","journal-title":"Rheumatology"},{"key":"10.1053\/j.tvir.2014.11.004_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/rheumatology\/32.6.524-a","article-title":"Amlodipine in the treatment of Raynaud\u05f3s phenomenon","volume":"32","author":"La Civita","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.tvir.2014.11.004_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00005344-199112000-00005","article-title":"Double-blind placebo-controlled crossover study of oral nicardipine in the treatment of Raynaud\u05f3s phenomenon","volume":"18","author":"Wollersheim","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.tvir.2014.11.004_bib10","first-page":"261","article-title":"Felodipine and isradipine: New calcium-channel-blocking agents for the treatment of hypertension","volume":"12","author":"Walton","year":"1993","journal-title":"Clin Pharm"},{"key":"10.1053\/j.tvir.2014.11.004_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/clpt.1986.166","article-title":"Double-blind, placebo-controlled study of prazosin in Raynaud\u05f3s phenomenon","volume":"40","author":"Wollersheim","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.tvir.2014.11.004_bib12","doi-asserted-by":"crossref","unstructured":"Stewart M, Morling JR: Oral vasodilators for primary Raynaud's phenom enon. Cochrane Database Syst Rev. Issue 7. Art. No.: CD006687, 2012. http:\/\/dx.doi.org\/10.1002\/14651858.CD006687.pub3","DOI":"10.1002\/14651858.CD006687.pub3"},{"key":"10.1053\/j.tvir.2014.11.004_bib13","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","article-title":"Losartan therapy for Raynaud\u05f3s phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial","volume":"42","author":"Dziadzio","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.tvir.2014.11.004_bib14","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1345\/aph.1H201","article-title":"Renin-angiotensin system mediators and Raynaud\u05f3s phenomenon","volume":"40","author":"Wood","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.tvir.2014.11.004_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/40.9.1038","article-title":"Treatment of Raynaud\u05f3s phenomenon with the selective serotonin reuptake inhibitor fluoxetine","volume":"40","author":"Coleiro","year":"2001","journal-title":"Rheumatology"},{"key":"10.1053\/j.tvir.2014.11.004_bib16","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/annrheumdis-2012-202836","article-title":"Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud\u05f3s phenomenon: Systematic review and meta-analysis of randomised trials","volume":"72","author":"Roustit","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.tvir.2014.11.004_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archinte.166.2.231","article-title":"Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease","volume":"166","author":"Caglayan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.tvir.2014.11.004_bib18","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud\u05f3s phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.tvir.2014.11.004_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/art.30195","article-title":"Modified-release sildenafil reduces Raynaud\u05f3s phenomenon attack frequency in limited cutaneous systemic sclerosis","volume":"63","author":"Herrick","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.tvir.2014.11.004_bib20","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/rheumatology\/keq291","article-title":"Efficacy of tadalafil in secondary Raynaud\u05f3s phenomenon resistant to vasodilator therapy: A double-blind randomized cross-over trial","volume":"49","author":"Shenoy","year":"2010","journal-title":"Rheumatology"},{"key":"10.1053\/j.tvir.2014.11.004_bib21","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinternmed.2012.2271","article-title":"Vardenafil for the treatment of Raynaud phenomenon: A randomized, double-blind, placebo-controlled crossover study","volume":"172","author":"Caglayan","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.tvir.2014.11.004_bib22","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/art.24351","article-title":"MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud\u05f3s phenomenon","volume":"60","author":"Chung","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.tvir.2014.11.004_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: Results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.tvir.2014.11.004_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3899\/jrheum.131284","article-title":"Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis","volume":"41","author":"Cutolo","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1053\/j.tvir.2014.11.004_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/ard.50.11.800","article-title":"A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud\u05f3s phenomenon secondary to connective tissue diseases","volume":"50","author":"Torley","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.tvir.2014.11.004_bib26","first-page":"503","article-title":"Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud\u05f3s phenomenon. A randomized, controlled study","volume":"19","author":"Scorza","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/j.tvir.2014.11.004_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.298.6673.561","article-title":"Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud\u05f3s phenomenon in patients with systemic sclerosis: A double blind randomised study","volume":"298","author":"Rademaker","year":"1989","journal-title":"Br Med J"},{"key":"10.1053\/j.tvir.2014.11.004_bib28","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/rheumatology\/37.9.952","article-title":"Oral iloprost in Raynaud\u05f3s phenomenon secondary to systemic sclerosis: A multicentre, placebo-controlled, dose-comparison study","volume":"37","author":"Black","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1053\/j.tvir.2014.11.004_bib29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I","article-title":"Oral iloprost treatment in patients with Raynaud\u05f3s phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study","volume":"41","author":"Wigley","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.tvir.2014.11.004_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00005344-199509000-00007","article-title":"Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud\u05f3s phenomenon: The acute vasodilatory effect is not sustained","volume":"26","author":"Kingma","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.tvir.2014.11.004_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jht.2013.12.003","article-title":"Current uses of botulinum toxin A as an adjunct to hand therapy interventions of hand conditions","volume":"27","author":"Kalliainen","year":"2014","journal-title":"J Hand Ther"},{"key":"10.1053\/j.tvir.2014.11.004_bib32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.anplas.2011.11.001","article-title":"Botulinum toxin type A contribution in the treatment of Raynaud\u05f3s phenomenon due to systemic sclerosis","volume":"58","author":"Serri","year":"2013","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1053\/j.tvir.2014.11.004_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.prs.0000244860.00674.57","article-title":"Management of vasospastic disorders with botulinum toxin A","volume":"119","author":"Van Beek","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1053\/j.tvir.2014.11.004_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jaad.2013.06.029","article-title":"A pilot study evaluating the efficacy of botulinum toxin A in the treatment of Raynaud phenomenon","volume":"69","author":"Jenkins","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.tvir.2014.11.004_bib35","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.jhsa.2011.07.011","article-title":"Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A","volume":"36","author":"Mannava","year":"2011","journal-title":"J Hand Surg"},{"key":"10.1053\/j.tvir.2014.11.004_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jvs.2011.01.069","article-title":"Thoracic sympathectomy for digital ischemia: A summary of evidence","volume":"54","author":"Coveliers","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.tvir.2014.11.004_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/jhsu.2002.35887","article-title":"Adventitial stripping of the radial and ulnar arteries in Raynaud\u05f3s disease","volume":"27","author":"Balogh","year":"2002","journal-title":"J Hand Surg"},{"key":"10.1053\/j.tvir.2014.11.004_bib38","first-page":"91","article-title":"Successful treatment of digital ulcers in a scleroderma patient with continuous bilateral thoracic sympathetic block","volume":"11","author":"Han","year":"2008","journal-title":"Pain Physician"},{"key":"10.1053\/j.tvir.2014.11.004_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/oxfordjournals.eurheartj.a061312","article-title":"Vasodilation induced by transcutaneous nerve stimulation in peripheral ischemia (Raynaud\u05f3s phenomenon and diabetic polyneuropathy)","volume":"3","author":"Kaada","year":"1982","journal-title":"Eur Heart J"},{"key":"10.1053\/j.tvir.2014.11.004_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000542-200501000-00032","article-title":"Successful use of spinal cord stimulation in the treatment of severe Raynaud\u05f3s disease of the hands","volume":"102","author":"Sibell","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1053\/j.tvir.2014.11.004_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0741-5214(05)80037-0","article-title":"Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort","volume":"23","author":"Landry","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.tvir.2014.11.004_bib42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jvs.2006.07.037","article-title":"Incidence and natural history of Raynaud phenomenon: a long-term follow up (14 years) of a random sample from the general population","volume":"44","author":"Carpentier","year":"2006","journal-title":"J Vasc Surg"}],"container-title":["Techniques in Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251614000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251614000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:53:01Z","timestamp":1761069181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089251614000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1089251614000602"],"URL":"https:\/\/doi.org\/10.1053\/j.tvir.2014.11.004","relation":{},"ISSN":["1089-2516"],"issn-type":[{"value":"1089-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raynaud Syndrome","name":"articletitle","label":"Article Title"},{"value":"Techniques in Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.tvir.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}